Prot #Pevonedistat-1015: A Phase 1 Study to Evaluate the Effects of Rifampin on Pharmacokinetics of Pevonedistat in Patients with Advanced Solid Tumors

Project: Research project

StatusActive
Effective start/end date11/28/1811/28/21

Funding

  • PRA Health Sciences (Prot #Pevonedistat-1015)
  • Millennium Pharmaceuticals, Inc (Prot #Pevonedistat-1015)